Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation.

Frontiers in oncology

Gorchs L, Hellevik T, Bruun JA, Camilio KA, Al-Saad S, Stuge TB, Martinez-Zubiaurre I.
PMID: 26029659
Front Oncol. 2015 May 12;5:87. doi: 10.3389/fonc.2015.00087. eCollection 2015.

Accumulating evidence supports the notion that high-dose (>5 Gy) radiotherapy (RT) regimens are triggering stronger pro-immunogenic effects than standard low-dose (2 Gy) regimens. However, the effects of RT on certain immunoregulatory elements in tumors remain unexplored. In this study,...

Cite
Gorchs L, Hellevik T, Bruun JA, et al. Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation. Front Oncol. 2015;5:87doi: 10.3389/fonc.2015.00087.
Gorchs, L., Hellevik, T., Bruun, J. A., Camilio, K. A., Al-Saad, S., Stuge, T. B., & Martinez-Zubiaurre, I. (2015). Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation. Frontiers in oncology, 587. https://doi.org/10.3389/fonc.2015.00087
Gorchs, Laia, et al. "Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation." Frontiers in oncology vol. 5 (2015): 87. doi: https://doi.org/10.3389/fonc.2015.00087
Gorchs L, Hellevik T, Bruun JA, Camilio KA, Al-Saad S, Stuge TB, Martinez-Zubiaurre I. Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation. Front Oncol. 2015 May 12;5:87. doi: 10.3389/fonc.2015.00087. eCollection 2015. PMID: 26029659; PMCID: PMC4429237.
Copy Download .nbib Format: NLM
SLEEP CYCLES IN PREMATURE INFANTS.

Developmental medicine and child neurology

GOLDIE L.
PMID: 14343231
Dev Med Child Neurol. 1965 Jun;7:317-9. doi: 10.1111/j.1469-8749.1965.tb10939.x.

No abstract available.

Cite
GOLDIE L. SLEEP CYCLES IN PREMATURE INFANTS. Dev Med Child Neurol. 1965;7:317-9doi: 10.1111/j.1469-8749.1965.tb10939.x.
GOLDIE, L. (1965). SLEEP CYCLES IN PREMATURE INFANTS. Developmental medicine and child neurology, 7317-9. https://doi.org/10.1111/j.1469-8749.1965.tb10939.x
GOLDIE, L. "SLEEP CYCLES IN PREMATURE INFANTS." Developmental medicine and child neurology vol. 7 (1965): 317-9. doi: https://doi.org/10.1111/j.1469-8749.1965.tb10939.x
GOLDIE L. SLEEP CYCLES IN PREMATURE INFANTS. Dev Med Child Neurol. 1965 Jun;7:317-9. doi: 10.1111/j.1469-8749.1965.tb10939.x. PMID: 14343231.
Copy Download .nbib Format: NLM
A new practitioner's guide to a successful interview.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

DeCoske MA, Cavanaugh T, Elliott S, Garris L, Giannakos M, Hegg AM, Kelley LR, Miller S, Weimert NA, Tanas M.
PMID: 18997136
Am J Health Syst Pharm. 2008 Nov 15;65(22):2100-3. doi: 10.2146/ajhp080257.

No abstract available.

Cite
DeCoske MA, Cavanaugh T, Elliott S, et al. A new practitioner's guide to a successful interview. Am J Health Syst Pharm. 2008;65(22):2100-3doi: 10.2146/ajhp080257.
DeCoske, M. A., Cavanaugh, T., Elliott, S., Garris, L., Giannakos, M., Hegg, A. M., Kelley, L. R., Miller, S., Weimert, N. A., & Tanas, M. (2008). A new practitioner's guide to a successful interview. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 65(22), 2100-3. https://doi.org/10.2146/ajhp080257
DeCoske, Michael A, et al. "A new practitioner's guide to a successful interview." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 65,22 (2008): 2100-3. doi: https://doi.org/10.2146/ajhp080257
DeCoske MA, Cavanaugh T, Elliott S, Garris L, Giannakos M, Hegg AM, Kelley LR, Miller S, Weimert NA, Tanas M. A new practitioner's guide to a successful interview. Am J Health Syst Pharm. 2008 Nov 15;65(22):2100-3. doi: 10.2146/ajhp080257. PMID: 18997136.
Copy Download .nbib Format: NLM
HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations.

Brain and behavior

Gerdes L, Gerdes P, Lee SW, H Tegeler C.
PMID: 23532171
Brain Behav. 2013 Mar;3(2):193-205. doi: 10.1002/brb3.116. Epub 2013 Jan 14.

Disturbances of neural oscillation patterns have been reported with many disease states. We introduce methodology for HIRREM™ (high-resolution, relational, resonance-based electroencephalic mirroring), also known as Brainwave Optimization™, a noninvasive technology to facilitate relaxation and auto-calibration of neural oscillations. HIRREM...

Cite
Gerdes L, Gerdes P, Lee SW, et al. HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations. Brain Behav. 2013;3(2):193-205doi: 10.1002/brb3.116.
Gerdes, L., Gerdes, P., Lee, S. W., & H Tegeler, C. (2013). HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations. Brain and behavior, 3(2), 193-205. https://doi.org/10.1002/brb3.116
Gerdes, Lee, et al. "HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations." Brain and behavior vol. 3,2 (2013): 193-205. doi: https://doi.org/10.1002/brb3.116
Gerdes L, Gerdes P, Lee SW, H Tegeler C. HIRREM™: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations. Brain Behav. 2013 Mar;3(2):193-205. doi: 10.1002/brb3.116. Epub 2013 Jan 14. PMID: 23532171; PMCID: PMC3607159.
Copy Download .nbib Format: NLM
Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012.

BMC medical informatics and decision making

Volk RJ, Street R, Smith Q, Fordis M.
PMID: 24625302
BMC Med Inform Decis Mak. 2013;13:S1. doi: 10.1186/1472-6947-13-S3-S1. Epub 2013 Dec 06.

No abstract available.

Cite
Volk RJ, Street R, Smith Q, et al. Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012. BMC Med Inform Decis Mak. 2013;13:S1doi: 10.1186/1472-6947-13-S3-S1.
Volk, R. J., Street, R., Smith, Q., & Fordis, M. (2013). Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012. BMC medical informatics and decision making, 13S1. https://doi.org/10.1186/1472-6947-13-S3-S1
Volk, Robert J, et al. "Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012." BMC medical informatics and decision making vol. 13 (2013): S1. doi: https://doi.org/10.1186/1472-6947-13-S3-S1
Volk RJ, Street R, Smith Q, Fordis M. Supporting informed decision making when clinical evidence and conventional wisdom collide: papers developed from the Eisenberg Center Conference Series 2012. BMC Med Inform Decis Mak. 2013;13:S1. doi: 10.1186/1472-6947-13-S3-S1. Epub 2013 Dec 06. PMID: 24625302; PMCID: PMC4028851.
Copy Download .nbib Format: NLM
What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?.

Journal of Alzheimer's disease & Parkinsonism

Aslam S, Fritz MA, Cordes L, Sabbagh MN.
PMID: 30733890
J Alzheimers Dis Parkinsonism. 2018;8(5). doi: 10.4172/2161-0460.1000452. Epub 2018 Oct 30.

BACKGROUND: Developing methods for accurately diagnosing prion diseases has been a challenge in the search for successful diagnosis and treatment of rapidly progressive dementia. prion diseases are rare. However, they should be considered in the differential diagnosis. Despite their...

Cite
Aslam S, Fritz MA, Cordes L, et al. What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?. J Alzheimers Dis Parkinsonism. 2018;8(5)doi: 10.4172/2161-0460.1000452.
Aslam, S., Fritz, M. A., Cordes, L., & Sabbagh, M. N. (2018). What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?. Journal of Alzheimer's disease & Parkinsonism, 8(5), . https://doi.org/10.4172/2161-0460.1000452
Aslam, Sana, et al. "What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?." Journal of Alzheimer's disease & Parkinsonism vol. 8,5 (2018). doi: https://doi.org/10.4172/2161-0460.1000452
Aslam S, Fritz MA, Cordes L, Sabbagh MN. What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia?. J Alzheimers Dis Parkinsonism. 2018;8(5). doi: 10.4172/2161-0460.1000452. Epub 2018 Oct 30. PMID: 30733890; PMCID: PMC6362841.
Copy Download .nbib Format: NLM
Predicting the IQ of young children from early developmental markers.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Dorris L.
PMID: 28187820
Eur J Paediatr Neurol. 2017 Mar;21(2):247. doi: 10.1016/j.ejpn.2017.01.005.

No abstract available.

Cite
Dorris L. Predicting the IQ of young children from early developmental markers. Eur J Paediatr Neurol. 2017;21(2):247doi: 10.1016/j.ejpn.2017.01.005.
Dorris, L. (2017). Predicting the IQ of young children from early developmental markers. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 21(2), 247. https://doi.org/10.1016/j.ejpn.2017.01.005
Dorris, Liam. "Predicting the IQ of young children from early developmental markers." European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society vol. 21,2 (2017): 247. doi: https://doi.org/10.1016/j.ejpn.2017.01.005
Dorris L. Predicting the IQ of young children from early developmental markers. Eur J Paediatr Neurol. 2017 Mar;21(2):247. doi: 10.1016/j.ejpn.2017.01.005. PMID: 28187820.
Copy Download .nbib Format: NLM
Symposium: the handicapped child [abridged].

Proceedings of the Royal Society of Medicine

Goldie L.
PMID: 20918880
Proc R Soc Med. 1966 Feb;59(2):145-6.

No abstract available.

Cite
Goldie L. Symposium: the handicapped child [abridged]. Proc R Soc Med. 1966;59(2):145-6
Goldie, L. (1966). Symposium: the handicapped child [abridged]. Proceedings of the Royal Society of Medicine, 59(2), 145-6.
Goldie, L. "Symposium: the handicapped child [abridged]." Proceedings of the Royal Society of Medicine vol. 59,2 (1966): 145-6.
Goldie L. Symposium: the handicapped child [abridged]. Proc R Soc Med. 1966 Feb;59(2):145-6. PMID: 20918880; PMCID: PMC1900805.
Copy Download .nbib Format: NLM
Licorice: From Pseudohyperaldosteronism to Therapeutic Uses.

Frontiers in endocrinology

Sabbadin C, Bordin L, Donà G, Manso J, Avruscio G, Armanini D.
PMID: 31379750
Front Endocrinol (Lausanne). 2019 Jul 18;10:484. doi: 10.3389/fendo.2019.00484. eCollection 2019.

Licorice has been used as a medicinal plant from 2.500 years. It shows a wide range of biological and pharmacological activities, including anti-inflammatory and immune regulatory actions. One of its most known effects is the induction of hypertension, and...

Cite
Sabbadin C, Bordin L, Donà G, et al. Licorice: From Pseudohyperaldosteronism to Therapeutic Uses. Front Endocrinol (Lausanne). 2019;10:484doi: 10.3389/fendo.2019.00484.
Sabbadin, C., Bordin, L., Donà, G., Manso, J., Avruscio, G., & Armanini, D. (2019). Licorice: From Pseudohyperaldosteronism to Therapeutic Uses. Frontiers in endocrinology, 10484. https://doi.org/10.3389/fendo.2019.00484
Sabbadin, Chiara, et al. "Licorice: From Pseudohyperaldosteronism to Therapeutic Uses." Frontiers in endocrinology vol. 10 (2019): 484. doi: https://doi.org/10.3389/fendo.2019.00484
Sabbadin C, Bordin L, Donà G, Manso J, Avruscio G, Armanini D. Licorice: From Pseudohyperaldosteronism to Therapeutic Uses. Front Endocrinol (Lausanne). 2019 Jul 18;10:484. doi: 10.3389/fendo.2019.00484. eCollection 2019. PMID: 31379750; PMCID: PMC6657287.
Copy Download .nbib Format: NLM
Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers.

Journal of oncology practice

Gordan L, Blazer M, Saundankar V, Kazzaz D, Weidner S, Eaddy M.
PMID: 30379608
J Oncol Pract. 2018 Oct 31;JOP1700040. doi: 10.1200/JOP.17.00040. Epub 2018 Oct 31.

PURPOSE:: Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether this shift could...

Cite
Gordan L, Blazer M, Saundankar V, et al. Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers. J Oncol Pract. 2018;JOP1700040doi: 10.1200/JOP.17.00040.
Gordan, L., Blazer, M., Saundankar, V., Kazzaz, D., Weidner, S., & Eaddy, M. (2018). Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers. Journal of oncology practice, JOP1700040. https://doi.org/10.1200/JOP.17.00040
Gordan, Lucio, et al. "Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers." Journal of oncology practice vol. (2018): JOP1700040. doi: https://doi.org/10.1200/JOP.17.00040
Gordan L, Blazer M, Saundankar V, Kazzaz D, Weidner S, Eaddy M. Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers. J Oncol Pract. 2018 Oct 31;JOP1700040. doi: 10.1200/JOP.17.00040. Epub 2018 Oct 31. PMID: 30379608.
Copy Download .nbib Format: NLM
Improving Transitions of Care for Young Adults With Congenital Heart Disease: Mobile App Development Using Formative Research.

JMIR formative research

Lopez KN, O'Connor M, King J, Alexander J, Challman M, Lovick DK, Goodly N, Smith A, Fawcett E, Mulligan C, Thompson D, Fordis M.
PMID: 30574573
JMIR Form Res. 2018 Jul-Dec;2(2). doi: 10.2196/formative.9963. Epub 2018 Jan 29.

BACKGROUND: Congenital heart diseases (CHDs) are the most common type of birth defects. Improvements in CHD care have led to approximately 1.4 million survivors reaching adulthood. Successful transition and transfer from pediatric to adult care is crucial. Unfortunately, less...

Cite
Lopez KN, O'Connor M, King J, et al. Improving Transitions of Care for Young Adults With Congenital Heart Disease: Mobile App Development Using Formative Research. JMIR Form Res. 2018;2(2)doi: 10.2196/formative.9963.
Lopez, K. N., O'Connor, M., King, J., Alexander, J., Challman, M., Lovick, D. K., Goodly, N., Smith, A., Fawcett, E., Mulligan, C., Thompson, D., & Fordis, M. (2018). Improving Transitions of Care for Young Adults With Congenital Heart Disease: Mobile App Development Using Formative Research. JMIR formative research, 2(2), . https://doi.org/10.2196/formative.9963
Lopez, Keila N, et al. "Improving Transitions of Care for Young Adults With Congenital Heart Disease: Mobile App Development Using Formative Research." JMIR formative research vol. 2,2 (2018). doi: https://doi.org/10.2196/formative.9963
Lopez KN, O'Connor M, King J, Alexander J, Challman M, Lovick DK, Goodly N, Smith A, Fawcett E, Mulligan C, Thompson D, Fordis M. Improving Transitions of Care for Young Adults With Congenital Heart Disease: Mobile App Development Using Formative Research. JMIR Form Res. 2018 Jul-Dec;2(2). doi: 10.2196/formative.9963. Epub 2018 Jan 29. PMID: 30574573; PMCID: PMC6298756.
Copy Download .nbib Format: NLM
Osteopathic Medicine and the Osteoporosis Management Gap.

The Journal of the American Osteopathic Association

Lowery JW, Baker J, Gebhardt GP, Gorbis S, Hoehn A, Hum JM, Nelligan L, Sefcik D, Wacker B, Wagner A, Williams D, Wright A.
PMID: 32750706
J Am Osteopath Assoc. 2020 Aug 04; doi: 10.7556/jaoa.2020.092. Epub 2020 Aug 04.

No abstract available.

Cite
Lowery JW, Baker J, Gebhardt GP, et al. Osteopathic Medicine and the Osteoporosis Management Gap. J Am Osteopath Assoc. 2020;doi: 10.7556/jaoa.2020.092.
Lowery, J. W., Baker, J., Gebhardt, G. P., Gorbis, S., Hoehn, A., Hum, J. M., Nelligan, L., Sefcik, D., Wacker, B., Wagner, A., Williams, D., & Wright, A. (2020). Osteopathic Medicine and the Osteoporosis Management Gap. The Journal of the American Osteopathic Association, . https://doi.org/10.7556/jaoa.2020.092
Lowery, Jonathan W, et al. "Osteopathic Medicine and the Osteoporosis Management Gap." The Journal of the American Osteopathic Association vol. (2020). doi: https://doi.org/10.7556/jaoa.2020.092
Lowery JW, Baker J, Gebhardt GP, Gorbis S, Hoehn A, Hum JM, Nelligan L, Sefcik D, Wacker B, Wagner A, Williams D, Wright A. Osteopathic Medicine and the Osteoporosis Management Gap. J Am Osteopath Assoc. 2020 Aug 04; doi: 10.7556/jaoa.2020.092. Epub 2020 Aug 04. PMID: 32750706.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries